Nigeria vs Zimbabwe: HIV/AIDS deaths averted by antiretroviral therapy
Nigeria
107,142 deaths
in 2024
Zimbabwe
84,960 deaths
in 2024
Nigeria rank
3rd
Zimbabwe rank
5th
HIV/AIDS deaths averted by antiretroviral therapy over time
- Nigeria
- Zimbabwe
How they compare
Nigeria currently reports 107,142 deaths against 84,960 deaths in Zimbabwe, a difference of 22,182 deaths.
That makes Nigeria's figure about 1.3 times Zimbabwe's.
The two have swapped places 7 times across 35 shared years of data; in 1990 it was Zimbabwe ahead.
Nigeria ranks 3rd and Zimbabwe ranks 5th of 157 countries.
Across the 4 decades both report, Nigeria averaged higher in 2 and Zimbabwe in 2.
Head to head by decade
| Decade | Nigeria | Zimbabwe | Difference | Ahead |
|---|---|---|---|---|
| 1990s | 0 deaths | 275.56 deaths | 275.56 deaths | Zimbabwe |
| 2000s | 16,764 deaths | 11,375 deaths | 5,389 deaths | Nigeria |
| 2010s | 74,507 deaths | 75,537 deaths | 1,030 deaths | Zimbabwe |
| 2020s | 101,103 deaths | 86,746 deaths | 14,356 deaths | Nigeria |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher hiv/aids deaths averted by antiretroviral therapy, Nigeria or Zimbabwe?
- Nigeria, at 107,142 deaths against 84,960 deaths in Zimbabwe as of 2024.
- What is the difference in hiv/aids deaths averted by antiretroviral therapy between Nigeria and Zimbabwe?
- 22,182 deaths, with Nigeria ahead.
- How many years of comparable data are there for Nigeria and Zimbabwe?
- 35 years are reported by both, from 1990 to 2024.
- How do Nigeria and Zimbabwe rank globally for hiv/aids deaths averted by antiretroviral therapy?
- Nigeria ranks 3rd and Zimbabwe ranks 5th of 157 countries.
- Where does this data come from?
- Joint United Nations Programme on HIV/AIDS (2026) – with minor processing by Our World in Data, published as HIV/AIDS deaths averted by antiretroviral therapy. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Number of deaths prevented as a direct result of Antiretroviral Therapy (ART) among people living with HIV. It is calculated by comparing the observed mortality rates in individuals receiving ART to the estimated mortality rates in the absence of such treatment. This is the central estimate.